Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 Investing Pro 0
🚨 Our Pro Data Reveals the True Winner of Earnings Season Access Data
Close

Pfizer Inc (PFE)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
40.400 +0.280    +0.70%
13:12:48 - Delayed Data. Currency in EUR ( Disclaimer )
  • Volume: 24,048
  • Bid/Ask: 40.340 / 40.400
  • Day's Range: 40.100 - 40.460
Type:  Equity
Market:  Germany
ISIN:  US7170811035 
WKN:  852009
Pfizer 40.400 +0.280 +0.70%

PFE Technical Analysis

 
Pfizer share technical analysis data, signals range from strong buy, buy, neutral, sell to strong Sell. Assess a detailed technical analysis based on the buy/sell signals of moving averages (simple and exponential for a wide range of periods) and buy, sell, overbought, oversold or neutral signals of common chart indicators (including RSI, MACD and CCI). View the PFE stock analysis data across your chosen time frame.
Summary:Buy
Moving Averages:BuyBuy (7)Sell (5)
Technical Indicators:BUYBuy (5)Sell (1)

Pivot PointsFeb 01, 2023 13:06 GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 40.120 40.200 40.240 40.320 40.360 40.440 40.480
Fibonacci 40.200 40.246 40.274 40.320 40.366 40.394 40.440
Camarilla 40.247 40.258 40.269 40.320 40.291 40.302 40.313
Woodie's 40.100 40.190 40.220 40.310 40.340 40.430 40.460
DeMark's - - 40.220 40.310 40.340 - -

Technical IndicatorsFeb 01, 2023 13:06 GMT

Name Value Action
RSI(14) 55.203 Buy
STOCH(9,6) 91.497 Overbought
STOCHRSI(14) 100.000 Overbought
MACD(12,26) -0.051 Sell
ADX(14) 29.683 Neutral
Williams %R 0.000 Overbought
CCI(14) 82.6656 Buy
ATR(14) 0.4457 High Volatility
Highs/Lows(14) 0.2757 Buy
Ultimate Oscillator 50.324 Neutral
ROC 0.298 Buy
Bull/Bear Power(13) 0.5520 Buy

Buy: 5

Sell: 1

Neutral: 2


Summary:BUY

Moving AveragesFeb 01, 2023 13:06 GMT

Period Simple Exponential
MA5 40.328
Buy 		40.275
Buy
MA10 40.000
Buy 		40.186
Buy
MA20 40.025
Buy 		40.134
Buy
MA50 40.422
Buy 		40.444
Sell
MA100 41.093
Sell 		41.383
Sell
MA200 43.502
Sell 		42.981
Sell

Buy: 7

Sell: 5


Summary:Buy

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rickard Costan
Rickard Costan Jan 27, 2023 19:35
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Project Veritas...
Reply
0 0
Report
Anon Anon
Anon Anon Oct 24, 2022 17:24
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Still aiming for sub 40
Reply
0 1
Report
Lee Baldwin
Lee Baldwin Mar 31, 2022 13:02
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Great long term er at this price
Reply
2 1
Report
Death Revenge
Death Revenge Feb 19, 2022 22:30
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
please never effective.inbox me for fast rising stocks
Reply
0 1
Report
Trevor Uren
Trevor Uren Feb 14, 2022 15:19
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Adverse Effects Rife
Reply
1 0
Report
Ali Atat
Ali Atat Jan 20, 2022 8:53
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
No logic for drop. This is a 60 Euro stock value
Reply
9 0
Report
Michael Potts
Michael Potts Jan 20, 2022 8:53
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It will drop like a stone, when the FDA release the data.
Reply
1 0
Report
Andrew Lees
Andrew Lees Jan 06, 2022 7:13
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
time to jump ship. New variants are weaker, hospitalisations are down, no longer a need for vaccine or meds. vaccine centres in the UK are now practically empty. It was a good two year ride, but time to bail.
Reply
2 4
Report
Timor Malul
Timor Malul Jan 05, 2022 15:45
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Strong buyPresident Biden has doubled commitment of the Pfizer pill treatment to at least 20 million courses as the Covid omicron variant rages.
Reply
4 0
Report
Basil Skater
Basil Skater Dec 17, 2021 16:28
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Why TF is this not rising ?
Reply
2 0
Report
Andrzej Bagiński
Andrzej Bagiński Nov 19, 2021 17:11
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The Covid Detector device has been added to the Register of rapid tests for the detection of SARS-CoV-2 virus in Austria. This instant contactless detector from ML System
Reply
1 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email